CD8+ T cells were usually considered the anti-tumor immune cells, but the enrichment of CD8+ T cells was associated with thyroid cancer recurrence, because CD8+ cells around tumor cells were found at the state of anergy [51]. The gene discussed is CD8A; the disease is thyroid gland carcinoma.